A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
The prospective, multi-center phase 3 PRIMARY randomized trial tested the additive diagnostic value of PSMA PET imaging in high-risk men with negative or equivocal MRI in the diagnosis of significant ...
A nationwide survey of prostate MRI practices in the UK revealed the universal adoption of pre-biopsy MRI across all NHS trusts, with 73.1% using multiparametric MRI protocols. However, significant ...
New service offers rapid, consultant-led prostate scans to support early detection and a proactive approach to men’s health ...
Later this week, the UK National Screening Committee (UKNSC), which advises the Government, publishes its final guidance on screening.
Detailed price information for Profound Medical Corp (PRN-T) from The Globe and Mail including charting and trades.
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...
The first men have taken part in a major UK trial testing new ways to screen for prostate cancer and detect the disease earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results